John Overdeck’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

John Overdeck’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-15,200	Closed	-$1.7M	–	4494
2021 Q4	$1.7M	Sell	15,200 -23,900	-61%	-$2.88M	﹤0.01%	2071
2021 Q3	$4.92M	Sell	39,100 -8,100	-17%	-$1.04M	0.01%	1241
2021 Q2	$6.39M	Buy	47,200 +44,200	+1,473%	+$5.81M	0.01%	1053
2021 Q1	$407K	Buy	+3,000	New	+$449K	﹤0.01%	3106
2020 Q3	–	Sell	-14,300	Closed	-$1.6M	–	3625
2020 Q2	$1.6M	Sell	14,300 -7,100	-33%	-$699K	0.01%	1223
2020 Q1	$1.66M	Buy	+21,400	New	+$1.89M	0.01%	1074
2019 Q4	–	Sell	-85,000	Closed	-$6.48M	–	4028
2019 Q3	$6.48M	Buy	85,000 +15,500	+22%	+$1.29M	0.02%	742
2019 Q2	$6.1M	Buy	69,500 +56,500	+435%	+$4.82M	0.02%	811
2019 Q1	$1.18M	Sell	13,000 -56,000	-81%	-$4.76M	﹤0.01%	1723
2018 Q4	$4.95M	Sell	69,000 -15,500	-18%	-$1.25M	0.02%	805
2018 Q3	$8.1M	Buy	84,500 +3,800	+5%	+$368K	0.02%	734
2018 Q2	$7.68M	Buy	80,700 +55,700	+223%	+$5.12M	0.02%	789
2018 Q1	$2.19M	Buy	25,000 +14,000	+127%	+$1.28M	0.01%	1457
2017 Q4	$934K	Buy	+11,000	New	+$922K	﹤0.01%	2021

Other funds holding XBI

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

JFG

Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return

John Overdeck's XBI Position: Q2 2026 in Review

John Overdeck increased its State Street SPDR S&P Biotech ETF (XBI) stake by 339% in Q2 2026, buying an estimated $156M and bringing the position to 1,497,968 shares worth $237M. The position accounts for 0.17% of the portfolio, ranked #123.

John Overdeck first reported a position in XBI in Q3 2018 and has held it in 24 quarters since. 931 funds tracked by Wall St. Rank hold XBI as of Q2 2026.

John Overdeck held 1,497,968 shares of State Street SPDR S&P Biotech ETF worth $237M as of Q2 2026.
John Overdeck bought 1,156,799 State Street SPDR S&P Biotech ETF shares in Q2 2026, an estimated $156M.
State Street SPDR S&P Biotech ETF made up 0.17% of John Overdeck's portfolio in Q2 2026, its #123 holding.
John Overdeck first reported a position in State Street SPDR S&P Biotech ETF in Q3 2018 and has held it in 24 quarters since.
931 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.

Based on Two Sigma Investments's 13F filing for Q2 2026, filed 14 Aug 2026.